CoQ10 supplementation is associated with headache resolution among pediatric patients with new daily persistent headache.

Most pediatric patients with migraine have normal imaging, supporting that routine scans rarely aid diagnosis or alter ...

Among children and adolescents with episodic migraine, fremanezumab significantly reduced monthly migraine days.

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief.

Mindfulness and transcranial direct current stimulation offer therapeutic benefit for reducing situational urgency urinary incontinence symptoms in women.

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura ...

Hearing loss may cause up to one-third of dementia cases in older adults, making it an important risk factor to address.

Intravenous thrombolysis in patients hospitalized for cervical artery dissection-related acute ischemic stroke increases the likelihood of home discharge.